Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:815-821

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, Q.-F.
Right arrow Articles by Graves, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, Q.-F.
Right arrow Articles by Graves, S. W.

(Hypertension. 1997;29:815-821.)
© 1997 American Heart Association, Inc.


Articles

Sodium Pump Isoform Specificity for the Digitalis-Like Factor Isolated From Human Peritoneal Dialysate

Qing-Feng Tao; Norman K. Hollenberg; Deborah A. Price; Steven W. Graves

the Departments of Medicine (Endocrine-Hypertension Division) and Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.

Correspondence to Dr Steven W. Graves, Endocrine-Hypertension Division, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115. E-mail swgraves@bics.bwh.harvard.edu

We have isolated a labile, specific sodium pump inhibitor or digitalis-like factor from the peritoneal dialysate of volume-expanded renal failure patients whose levels correlated closely with volume status and blood pressure. This study characterizes the inhibitory profile of this agent compared with that of ouabain against the three {alpha}-isoforms of the sodium pump. We prepared microsomal Na,K-ATPase from rat tissues representing the highest proportion of one of the {alpha}-isoforms. Both Northern and Western blot analyses confirmed that kidney had predominantly the {alpha}1-isoform, skeletal muscle the {alpha}2-isoform, and fetal brain the {alpha}3-isoform. Ouabain (5x10-6 mol/L) produced little inhibition of kidney Na,K-ATPase (3.4±2.0%) but significant inhibition of skeletal muscle (37.2±3.7%, P<.001) and fetal brain (38.8±3.5%, P<.001) activity. In contrast, the labile digitalis-like factor, causing comparable inhibition of fetal brain Na,K-ATPase activity (33.3±4.7%), produced markedly greater inhibition of kidney (42.5±5.6%, P<.001) and moderately greater inhibition of skeletal muscle pump activity (57.7±6.3%, P<.05). In addition, the labile digitalis-like factor produced a marked concentration-dependent inhibition of the {alpha}2- and {alpha}3-isoforms (r=.79, P=.00005). Experiments combining the labile digitalis-like factor and ouabain confirmed that digitalis-like factor, unlike ouabain, was an effective inhibitor of all three isoforms in rat, in particular {alpha}2. The different pattern of isoform sensitivity displayed by the labile digitalis-like factor and ouabain further differentiates the two agents and raises some interesting possibilities about the functional implications of the endogenous factor.


Key Words: mRNA • Western blot analysis • ouabain • Na+,K+-transporting ATPase • sodium pump • digitalis-like factor




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Wasserstrom and G. L. Aistrup
Digitalis: new actions for an old drug
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1781 - H1793.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. M.A.M. Qazzaz, Z. Cao, D. D. Bolanowski, B. J. Clark, and R. Valdes Jr
De Novo Biosynthesis and Radiolabeling of Mammalian Digitalis-Like Factors
Clin. Chem., March 1, 2004; 50(3): 612 - 620.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
N. Shimoda, J. Jasleen, J. D. Rounds, S. W. Ashley, and D. O. Jacobs
Sepsis Increases the Plasma Membrane Content of {alpha}1 and {alpha}2 Isoforms of Na+-K+ Adenosine Triphosphatase in Rat Skeletal Muscle
Arch Surg, January 1, 2001; 136(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. W. Graves, K. E. Markides, and N. K. Hollenberg
Application of Supercritical Fluid Chromatography to Characterize a Labile Digitalis-Like Factor
Hypertension, December 1, 2000; 36(6): 1059 - 1064.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. M. A. M. Qazzaz, M. A. El-Masri, and R. Valdes Jr.
Secretion of a Lactone-Hydrogenated Ouabain-Like Effector of Sodium, Potassium-Adenosine Triphosphatase Activity by Adrenal Cells
Endocrinology, September 1, 2000; 141(9): 3200 - 3209.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q.-F. Tao, N. K. Hollenberg, and S. W. Graves
Sodium Pump Inhibition and Regional Expression of Sodium Pump {alpha}-Isoforms in Lens
Hypertension, November 1, 1999; 34(5): 1168 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. N. Orlov, N. C. Adragna, V. A. Adarichev, and P. Hamet
Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension
Am J Physiol Cell Physiol, March 1, 1999; 276(3): C511 - C536.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Y. Bagrov, O. V. Fedorova, R. I. Dmitrieva, W. N. Howald, A. P. Hunter, E. A. Kuznetsova, and V. M. Shpen
Characterization of a Urinary Bufodienolide Na+,K+-ATPase Inhibitor in Patients After Acute Myocardial Infarction
Hypertension, May 1, 1998; 31(5): 1097 - 1103.
[Abstract] [Full Text] [PDF]